In Chronic hepatitis C virus (HCV) infection Ropegus 200mg Tablet works by preventing the HCV virus from multiplying in your body. It helps control the infection and makes the immune system work better. This lowers your chances of getting complications and improves your quality of life. This medicine is always taken in combination with other antiretroviral medicines. It is not a cure and should neither be used to prevent HCV infection. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor. Taking all doses in the right amount at the right times greatly increases the effectiveness of the medicine.
It is not known whether it is safe to consume alcohol with Ropegus 200mg Tablet. Please consult your doctor.
Ropegus 200mg Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Ropegus 200mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Ropegus 200mg Tablet does not usually affect your ability to drive.
Ropegus 200mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Ropegus 200mg Tablet may be needed. Please consult your doctor. Use of Ropegus 200mg Tablet is not recommended in patients with moderate to severe kidney disease.
There is limited information available on the use of Ropegus 200mg Tablet in patients with liver disease. Please consult your doctor.
If you miss a dose of Ropegus 200mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Aprazer Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lupin Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Fulford India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Johnlee Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Biocon || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cmg Biotech Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Johnlee Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: United Biotech Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Hetero Drugs Ltd || ₹14.5/tablet (25% cheaper)